Cadrenal Therapeutics, Inc. Balance Sheet
Cadrenal Therapeutics, Inc.'s total assets for Q4 2025 were $4.33M, an increase of 5.85% from the previous quarter. CVKD total liabilities were $1.59M for the fiscal quarter, a 17.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.